RMFCX
Price
$62.47
Change
+$0.39 (+0.63%)
Updated
Jun 2 closing price
Net Assets
114.65B
TRZAX
Price
$53.75
Change
+$0.45 (+0.84%)
Updated
Jun 2 closing price
Net Assets
33.31B
Interact to see
Advertisement

RMFCX vs TRZAX

Header iconRMFCX vs TRZAX Comparison
Open Charts RMFCX vs TRZAXBanner chart's image
RMFCX vs TRZAX Comparison Chart in %
View a ticker or compare two or three
VS
RMFCX vs. TRZAX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMFCX is a Hold and TRZAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 115B vs. TRZAX (33.3B). TRZAX pays higher dividends than RMFCX: TRZAX (1.42) vs RMFCX (1.19). RMFCX was incepted earlier than TRZAX: RMFCX (24 years) vs TRZAX (6 years). RMFCX (0.91) is less costly to investors than TRZAX (0.56). TRZAX is a more actively managed with annual turnover of: 59.50 vs. RMFCX (30.00). TRZAX has a lower initial minimum investment than RMFCX: TRZAX (0) vs RMFCX (250). TRZAX annual gain was more profitable for investors over the last year : 16.55 vs. RMFCX (10.10). RMFCX return over 5 years is better than : 33.85 vs. TRZAX (17.97).
RMFCXTRZAXRMFCX / TRZAX
Total Expense Ratio0.910.00-
Annual Report Gross Expense Ratio0.910.56163%
Fund Existence24 years6 years-
Gain YTD5.84511.43651%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets115B33.3B345%
Annual Yield % from dividends1.191.4283%
Returns for 1 year10.1016.5561%
Returns for 3 years34.6544.4778%
Returns for 5 years33.8517.97188%
Returns for 10 years91.46N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SIBLX30.92N/A
N/A
Touchstone Balanced Y
SPSDX20.32N/A
N/A
Sterling Capital Behav Sm Cp Val Eq C
MEGMX22.28N/A
N/A
Matthews Emerging Markets Equity Inv
SMGIX42.74N/A
N/A
Columbia Contrarian Core Inst
BMSRX16.56N/A
N/A
MFS Blended Research Mid Cap Eq R1